Nghiêm Ngọc

Nghi Nguyen serves as the Vice President of Corporate Development at AnaptysBio since September 2023, focusing on innovative immunology therapeutics. Prior to this role, Nghi held the position of Vice President and Head of Corporate Development at Medikine, Inc., where responsibilities included shaping corporate strategy and driving deal negotiations. Nghi's prior experience also includes positions at Ascendis Pharma A/S, Global Blood Therapeutics, Aptose Biosciences, L'Oréal, and Wedbush Securities, encompassing business development, corporate strategy, and investment banking within the life sciences sector. Nghi holds a Master of Science in Management Science and a Bachelor of Science in Biological Sciences from Stanford University, with a foundation in research related to stem cell biology.